[ad_1]
◀ Anchor ▶
We’ll tell you in detail about the spread of Corona 19 in a moment, and today’s news starts with MBC’s exclusive report on hope-giving preventive vaccines like Danbi.
It has been confirmed that enough vaccines have already been obtained, more than 30 million government targets.
We plan to bring in vaccines from five pharmaceutical companies, including Pfizer and Modena, which have announced a prevention effect of more than 90%, and sequentially.
Reporter Park Sun-ha covered it.
◀ Report ▶
The government’s goal is to ensure a vaccine for 30 million people in advance that can be adapted to 60% of our population.
The government already started negotiations with pharmaceutical companies in June, but has recently been in contact with two or three pharmaceutical companies each week to speed up the negotiations.
As a result, it was confirmed that MBC has already insured more than 30 million people, surpassing the original goal of 20 million people, which was to be insured through individual pharmaceutical companies, and including the amount of the joint purchase of Cobax.
It was delivered in sufficient quantity to inoculate more than 60% of the population.
There are also many types of vaccines available.
It is not a single product, but a variety of products that enter sequentially.
At least five companies, including Pfizer and Modena, AstraZeneca, Johnson & Johnson, and NovaVax, were uniformly incorporated.
Each vaccine has a fixed production quantity, and since countries around the world are competing, it can be difficult to obtain sufficient quantities if negotiated with just one or two companies.
Furthermore, although Pfizer and Modena showed 95% effectiveness, it was also considered that as the first vaccine to use the nucleic acid method, there were many variables such as mass production and cryogenic distribution.
How much each pharmaceutical company will contribute has almost been decided and negotiations are known to be in the final stage.
It is also planned to reduce the KFDA approval period, which normally takes around 180 days, to about a month, but the AstraZeneca vaccine has already begun preliminary review by the KFDA.
Furthermore, although negotiations with China’s Sinoparm have not yet advanced, it is reported that the possibility of negotiation has been opened if the results of the clinical trial are determined to be stable.
Although the amount of vaccine introduced has been secured, the vaccine is expected to be after March next year at the earliest, considering safety.
[권준욱 제2부본부장/중앙방역대책본부 (지난 17일)]“It’s reasonable to check and start by adding up to 500,000 to 1 million side effects, and that it may not be too late to start (I’m making a judgment).”
The government will announce plans for the number and type of vaccines insured and priorities for vaccines by the end of next week.
This is Seonha Park from MBC News.
(Video editing: Kim Jong-un)
MBC News awaits your report 24 hours a day.
▷ Telephone 02-784-4000
▷ Email [email protected]
▷ Report from KakaoTalk @mbc
